Publication | Open Access
An Open-Label Study of Nefazodone Treatment of Major Depression in Patients with Congestive Heart Failure
37
Citations
29
References
2003
Year
It is feasible to screen and recruit CHF patients with major depression for an anti-depressant trial. Nefazodone seems sufficiently safe, tolerable, and efficacious to justify a larger, placebo-controlled trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1